This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1978 Oct 26;299(17):955.

doi: 10.1056/NEJM197810262991715.

Possible interaction of sulfinpyrazone with coumarins

J W Davis, L E Johns Jr

PMID: 692605
DOI: 10.1056/NEJM197810262991715

Possible interaction of sulfinpyrazone with coumarins

J W Davis et al. N Engl J Med. 1978.

. 1978 Oct 26;299(17):955.

doi: 10.1056/NEJM197810262991715.

Authors

J W Davis, L E Johns Jr

PMID: 692605
DOI: 10.1056/NEJM197810262991715

No abstract available

PubMed Disclaimer

Similar articles

Phenylbutazone and sulfinpyrazone interaction with oral anticoagulant phenprocoumon.
O'Reilly RA. O'Reilly RA. Arch Intern Med. 1982 Sep;142(9):1634-7. Arch Intern Med. 1982. PMID: 7114982
Stereoselective interaction of sulfinpyrazone with racemic warfarin and its separated enantiomorphs in man.
O'Reilly RA. O'Reilly RA. Circulation. 1982 Jan;65(1):202-7. doi: 10.1161/01.cir.65.1.202. Circulation. 1982. PMID: 7053283 Clinical Trial.
Potentially serious interaction of warfarin with sulphinpyrazone.
Thompson PL, Serjeant C. Thompson PL, et al. Med J Aust. 1981 Jan 10;1(1):41. doi: 10.5694/j.1326-5377.1981.tb135291.x. Med J Aust. 1981. PMID: 7207296 No abstract available.
Hemorrhage while on anticoagulant therapy precipitated by drug interaction.
Taylor PJ. Taylor PJ. Ariz Med. 1967 Aug;24(8):697-9. Ariz Med. 1967. PMID: 6056202 No abstract available.
Drug interactions with coumarin anticoagulants. 2.
Weser JK, Sellers E. Weser JK, et al. N Engl J Med. 1971 Sep 2;285(10):547-58. doi: 10.1056/NEJM197109022851005. N Engl J Med. 1971. PMID: 4397794 Review. No abstract available.

See all similar articles

Cited by

Hazards of sulphinpyrazone.
Mattingly D, Bradley M, Selley PJ. Mattingly D, et al. Br Med J. 1978 Dec 23-30;2(6154):1786-7. doi: 10.1136/bmj.2.6154.1786-c. Br Med J. 1978. PMID: 310703 Free PMC article. No abstract available.
Biphasic sulphinpyrazone-warfarin interaction.
Nenci GG, Agnelli G, Berrettini M. Nenci GG, et al. Br Med J (Clin Res Ed). 1981 Apr 25;282(6273):1361-2. doi: 10.1136/bmj.282.6273.1361. Br Med J (Clin Res Ed). 1981. PMID: 6786498 Free PMC article. No abstract available.
Importance of drug enantiomers in clinical pharmacology.
Williams K, Lee E. Williams K, et al. Drugs. 1985 Oct;30(4):333-54. doi: 10.2165/00003495-198530040-00003. Drugs. 1985. PMID: 3905334 Review.
Antiplatelet drugs: clinical pharmacology and therapeutic use.
Gallus AS. Gallus AS. Drugs. 1979 Dec;18(6):439-77. doi: 10.2165/00003495-197918060-00002. Drugs. 1979. PMID: 391530 Review.
Clinical pharmacokinetics and potentially important drug interactions of sulphinpyrazone.
Pedersen AK, Jakobsen P, Kampmann JP, Hansen JM. Pedersen AK, et al. Clin Pharmacokinet. 1982 Jan-Feb;7(1):42-56. doi: 10.2165/00003088-198207010-00003. Clin Pharmacokinet. 1982. PMID: 7042172 Review. No abstract available.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.